5,6-二氢-5-氮杂胞苷用于胸膜恶性间皮瘤的II期试验 - Suppr

Suppr

超能文献

Phase II trial of 5,6-dihydro-5-azacytidine in pleural malignant mesothelioma.

作者信息

Dhingra H M, Murphy W K, Winn R J, Raber M N, Hong W K

机构信息

Department of Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston 77030.

出版信息

Invest New Drugs. 1991 Feb;9(1):69-72. doi: 10.1007/BF00194548.

DOI:10.1007/BF00194548

PMID:1709153

Abstract

摘要

相似文献

Phase II trial of 5,6-dihydro-5-azacytidine in pleural malignant mesothelioma.5,6-二氢-5-氮杂胞苷用于胸膜恶性间皮瘤的II期试验

Invest New Drugs. 1991 Feb;9(1):69-72. doi: 10.1007/BF00194548.

Dihydro-5-azacytidine in malignant mesothelioma. A phase II trial demonstrating activity accompanied by cardiac toxicity. Cancer and Leukemia Group B.二氢-5-氮杂胞苷治疗恶性间皮瘤。一项显示有活性但伴有心脏毒性的II期试验。癌症与白血病B组。

Cancer. 1997 Jun 1;79(11):2237-42. doi: 10.1002/(sici)1097-0142(19970601)79:11<2237::aid-cncr23>3.0.co;2-w.

Dihydro-5-azacytidine and cisplatin in the treatment of malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B.二氢-5-氮杂胞苷和顺铂治疗恶性间皮瘤：癌症与白血病B组的一项II期研究

Cancer. 1998 Apr 15;82(8):1578-84.

Phase II study of 5,6-dihydro-5-azacytidine in extensive, untreated non-small cell lung cancer.5,6-二氢-5-氮杂胞苷用于广泛期、未经治疗的非小细胞肺癌的II期研究。

Cancer Treat Rep. 1987 Sep;71(9):859-60.

[Medical treatment of malignant pleural mesothelioma. Role of pemetrexed in current treatment].[恶性胸膜间皮瘤的医学治疗。培美曲塞在当前治疗中的作用]

Rev Pneumol Clin. 2005 Sep;61(4 Pt 2):4S10-3.

Premature senescence induced by DNA demethylating agent (Decitabine) as therapeutic option for malignant pleural mesothelioma.DNA 去甲基化剂（地西他滨）诱导的过早衰老作为恶性胸膜间皮瘤的治疗选择。

Lung Cancer. 2011 Jan;71(1):113-5. doi: 10.1016/j.lungcan.2010.10.016. Epub 2010 Nov 20.

Capecitabine in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (39807).卡培他滨治疗恶性间皮瘤：癌症与白血病B组的一项II期试验（39807）

Lung Cancer. 2004 May;44(2):251-9. doi: 10.1016/j.lungcan.2003.10.011.

Phase II trial of vindesine in malignant pleural mesothelioma.

Cancer Treat Rep. 1987 Feb;71(2):205-6.

Phase II study of pemetrexed with and without folic acid and vitamin B12 as front-line therapy in malignant pleural mesothelioma.培美曲塞联合或不联合叶酸和维生素B12作为恶性胸膜间皮瘤一线治疗的II期研究。

J Clin Oncol. 2003 Apr 15;21(8):1556-61. doi: 10.1200/JCO.2003.06.122.

The issue of studies evaluating biomarkers which predict outcome after pemetrexed-based chemotherapy in malignant pleural mesothelioma.评估预测培美曲塞为基础的化疗后恶性胸膜间皮瘤预后生物标志物的研究问题。

J Thorac Oncol. 2013 Aug;8(8):e80-2. doi: 10.1097/JTO.0b013e31829b1cf9.

引用本文的文献

An extended phase II trial of ifosfamide plus mesna in malignant mesothelioma.异环磷酰胺联合美司钠治疗恶性间皮瘤的扩展II期试验。

Invest New Drugs. 1992 Nov;10(4):337-43. doi: 10.1007/BF00944192.

本文引用的文献

Diffuse malignant mesothelioma. Prospective evaluation of 69 patients.弥漫性恶性间皮瘤。69例患者的前瞻性评估。

Ann Intern Med. 1982 Jun;96(6 Pt 1):746-55. doi: 10.7326/0003-4819-96-6-746.

Malignant mesothelioma of the pleura: a study of 52 treated and 64 untreated patients.胸膜恶性间皮瘤：52例接受治疗患者和64例未接受治疗患者的研究。

Thorax. 1984 Apr;39(4):255-9. doi: 10.1136/thx.39.4.255.

Malignant mesothelioma 1982: review of 4710 published cases.1982年恶性间皮瘤：4710例已发表病例综述

Br J Dis Chest. 1983 Oct;77(4):321-43.

Phase II study of 5,6-dihydro-5-azacytidine in extensive, untreated non-small cell lung cancer.5,6-二氢-5-氮杂胞苷用于广泛期、未经治疗的非小细胞肺癌的II期研究。

Cancer Treat Rep. 1987 Sep;71(9):859-60.

Fetal hemoglobin gene activation in a phase II study of 5,6-dihydro-5-azacytidine for bronchogenic carcinoma.

Cancer Res. 1987 Aug 1;47(15):4199-201.

A phase I and pharmacokinetic study of dihydro-5-azacytidine (NSC 264880).二氢-5-氮杂胞苷（NSC 264880）的I期药代动力学研究

Cancer Res. 1985 Jul;45(7):3359-63.

Synthesis and antitumor activity of dihydro-5-azacytidine, a hydrolytically stable analogue of 5-azacytidine.二氢-5-氮杂胞苷（5-氮杂胞苷的一种水解稳定类似物）的合成与抗肿瘤活性

J Med Chem. 1977 Jun;20(6):806-12. doi: 10.1021/jm00216a013.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验